Four pharmaceutical manufacturers have removed their medicines which suppress stomach acid from SA shelves and another two drugmakers have quarantined their imports over safety concerns, according to SA’s medicines regulator.

The development has been triggered by a global scare about ranitidine, the active ingredient in these products, which has been found to contain traces of a potentially carcinogenic substance called N-nitrosodimethylamine (NDMA).

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Times Select.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00.